Hereditary hypofibrinogenemia in primary care pediatrics: a case report
Acta Biomedica Scientifica · 02.08.2026 · 11 (3) · 117-123
DOI: 10.29413/abs.2026-11.3.14 ↗Kurz gefasst
Fallbericht in der Zeitschrift Acta Biomedica Scientifica, online erschienen am 02.08.2026. Verfasst von M. V. Gomellya und 4 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Introduction
Hypofibrinogenemia is a rare coagulation disorder characterized by reduced plasma fibrinogen levels and an increased risk of hemorrhagic complications. Inherited forms, caused by mutations in the FGA, FGB, or FGG genes, have an estimated prevalence of 1:500,000 and often remain undiagnosed due to an asymptomatic course.
Aim
To present a rare clinical case of hereditary hypofibrinogenemia with a paucisymptomatic course in a child, in order to address challenges in diagnosis, long-term follow-up, and determining indications for prophylactic therapy to prevent hemorrhagic complications. Materials and Methods . We report a clinical case of hereditary hypofibrinogenemia in an 8-year-old child. The diagnosis was suspected incidentally during a routine pediatric examination. The diagnosis was subsequently confirmed by a hematologist based on persistently low fibrinogen levels, a positive family history (maternal hereditary hypofibrinogenemia), and genetic testing. Differential diagnosis with acquired forms of hypofibrinogenemia was performed based on clinical and laboratory evaluation, including complete blood count, coagulogram, aggregatogram, biochemical parameters, and instrumental studies.
Results
The key feature of this case was the mild clinical presentation, which included a neonatal cephalohematoma, a single episode of blood in stool, and rare epistaxis. This aligns with literature data on the highly variable phenotypic expressivity of hypofibrinogenemia. The importance of a detailed family history and genetic testing in diagnosing inherited coagulopathies, even in the absence of overt bleeding, is emphasized.
Conclusion
This case highlights the need for physician vigilance regarding inherited coagulation disorders in patients with abnormal coagulation test results, even in the absence of significant clinical symptoms. The development and implementation of strategies for long-term patient monitoring and the prevention of potential hemostasis-related risks are of paramount importance.
Zitieren
APA
Gomellya, M. V., Krupskaya, T. S., Belkova, T. Y., Vorzhеva, A. N., & Mironova, A. V. (2026). Hereditary hypofibrinogenemia in primary care pediatrics: a case report. Acta Biomedica Scientifica, 11(3), 117-123. https://doi.org/10.29413/abs.2026-11.3.14
Vancouver
Gomellya MV, Krupskaya TS, Belkova TY, Vorzhеva AN, Mironova AV. Hereditary hypofibrinogenemia in primary care pediatrics: a case report. Acta Biomedica Scientifica. 2026;11(3):117-123. doi:10.29413/abs.2026-11.3.14
BibTeX
@article{Gomellya2026,
author = {Gomellya, M. V. and Krupskaya, T. S. and Belkova, T. Yu. and Vorzhеva, A. N. and Mironova, A. V.},
title = {Hereditary hypofibrinogenemia in primary care pediatrics: a case report},
journal = {Acta Biomedica Scientifica},
year = {2026},
volume = {11},
number = {3},
pages = {117--123},
doi = {10.29413/abs.2026-11.3.14}
}
EUVIMED